The Financial Express12h
FDA gives nod to first rapid-acting insulin biosimilar for diabetes treatment
The U.S. Food and Drug Administration (USFDA) on Friday approved Merilog as biosimilar to Novolog (insulin aspart) for the ...
Why a big belly is bad for your brain health
Most of us are aware that excess weight around the belly in middle age raises our risk of developing a long list of health ...
Expert reveals the 3 signs your tiredness is something more sinister
One recent YouGov study found that 1 in 8 Brits report feeling tired 'all the time'. There's even a medical acronym for it: ...
Healio21h
FDA approves subcutaneous Merilog for glycemic control in diabetes
The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...
Live Science on MSN18h
What Is Type 3 Diabetes?
While most of us are familiar with type 1 and type 2 diabetes, you may not have come across the term ‘type 3 diabetes’ before.
FDA approves Sanofi biosimilar product for treatment of diabetes
The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...